| 股票代码 | 002589 | 当期评分 | ||||
| 股票名称 | 瑞康医药 | |||||
| 报告日期 | 2018-12-31 | 2019-12-31 | 2020-09-30 | 2020-09-30 | 2020-09-30 | 2020-09-30 |
| 每股经营现金流(¥) | -0.1126 | 1.392 | 0.2014 | 0.2014 | 0.2014 | ✘ |
| 销售净利润率(%) | 3.7673 | -1.2337 | 3.1608 | 3.1608 | 3.1608 | ✘ |
| 销售毛利率(%) | 18.7741 | 18.9378 | 18.6523 | 18.6523 | 18.6523 | ✘ |
| 净资产收益率(%) | 9.21 | -12.91 | 4.12 | 4.12 | 4.12 | ✘ |
| 营业增长率(%) | 45.613 | 3.9506 | -25.7558 | -25.7558 | -25.7558 | ✘ |
| 净利润增长率(%) | -6.6242 | -134.0412 | -33.0806 | -33.0806 | -33.0806 | ✘ |
| 每股收益(%) | 0.517 | -0.62 | 0.14 | 0.06 | 0.205 | ✔ |
| 现金流量比率(%) | -0.7964 | 10.138 | 0.9159 | 0.7288 | 1.3458 | ✔ |
| 三项费用比重(%) | 12.5667 | 13.9795 | 14.2243 | 14.3653 | 14.4126 | ✔ |
| 每股净资产(¥) | 5.6166 | 4.776 | 4.9158 | 4.8395 | 4.9812 | ✔ |
| 流动比率(%) | 1.3472 | 1.3435 | 1.2628 | 1.3285 | 1.2689 | ✔ |
| 速动比率(%) | 1.1356 | 1.167 | 1.1255 | 1.1665 | 1.1348 | ✔ |
| 现金比率(%) | 14.4234 | 23.3804 | 27.2397 | 30.7122 | 30.7122 | ✔ |
| 总资产利润率(%) | 4.134 | -1.2926 | 1.2052 | 0.4811 | 1.9209 | ✘ |
| 主营利润比重% | 324.4569 | 6522.2414 | 442.2249 | 582.7824 | 426.0467 | ✔ |
| 应收账款(万元) | 1,716,262.43 | 1,563,858.13 | 1,515,435.02 | 1,499,779.79 | 1,530,861.63 | ✔ |
| 应收票据(万元) | 81,724.64 | 14,200.48 | 15,033.37 | 8,756.65 | 25,862.13 | ✔ |
| 预付款项(万元) | 150,387.44 | 117,859.17 | 132,232.87 | 129,011.59 | 135,031.22 | ✘ |
| 存货(万元) | 450,202.86 | 364,760.39 | 308,650.21 | 357,765.56 | 302,086.56 | ✔ |
| 在建工程(万元) | 49,469.57 | 78,059.76 | 94,402.72 | 81,601.34 | 95,116.82 | ✔ |
| 应付款项(万元) | 551,881.79 | 530,350.15 | 446,968.53 | 495,889.07 | 511,880.89 | ✘ |
| 长期借款(万元) | 22,544.77 | 2,676.15 | 4,957.60 | 3,640.20 | 3,270.00 | ✔ |
| 未分配利润(万元) | 285,613.22 | 183,475.75 | 204,505.78 | 193,036.27 | 214,347.67 | ✔ |
| 商誉(万元) | 330,840.95 | 126,391.53 | 85,780.02 | 125,041.05 | 84,782.15 | ✔ |
| 流动资产(万元) | 617,613.12 | 470,805.00 | 481,745.85 | 483,748.99 | 479,986.94 | ✔ |
| 流动负债(万元) | 2,127,371.91 | 2,066,009.29 | 2,248,158.60 | 2,208,590.40 | 2,251,515.89 | ✔ |
瑞康医药002589评分结果 | 60.61分 | 卖出/减持 | ||||